Market Overview

Catalent To Purchase Bristol-Myers Squibb Manufacturing Facility In Italy


Catalent Inc (NYSE: CTLT) will purchase a Bristol-Myers Squibb (NYSE: BMY) manufacturing facility in Anagni, Italy.

No terms have been disclosed yet.

On Wednesday, Catalent shares traded down 0.4% to $50.40. Bristol-Myers Squibb shares traded up 0.59% at $48.05.

Related links:

Nikkei: Apple Could Shift Some Production Capacity Out Of China

My Size Rallies On Integration With 'Global' Apparel Company's E-Commerce Platform

Posted-In: News Asset Sales


Related Articles (BMY + CTLT)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

UPS Warns Training Regulations Will Hurt Its Long-Haul Driver Hiring

Newmark Group Reports Purchase Of ACRES